Start learning 50% faster. Sign in now
The Indian Pharmaceuticals industry plays a prominent role globally. India ranks 3rd worldwide for production by volume and 14th by value. The nation is the largest provider of generic medicines globally, occupying a 20% share in global supply by volume, and is the leading vaccine manufacturer globally. DCGI acts as an appellate authority in case of disputes regarding the quality of drugs and prepares and maintains the national reference standard for drugs. Furthermore, DCGI is the central licensing authority for medical devices that fall under the Medical Device Rules 2017.
Long-term borrowings are essential for supporting a company's large-scale investments and capital expenditures. These borrowings typically have extended...
Which of the following statements is/are correct about Gift City's International Financial Services Centre (IFSC)?
1) It is a global financ...
What does ‘R’ in CRILC stand for?
...The risk that loss may arise on account of trading in SLR and other securities by a bank is classified as ______
Which European financial regulatory body revoked CCIL’s recognition?
As per IRAC norms, an asset becomes NPA when the interest or installment remains overdue for more than:
Self Reliant India (SRI) Fund Scheme of the Ministry of MSME provides equity funding to those MSMEs which have the potential and viability to grow and b...
Which of the following instruments is commonly used by banks to manage short-term liquidity needs?
What does Provisioning Coverage Ratio (PCR) indicate?
A stock is selling at Rs 50. An analyst’s valuation model estimates its intrinsic value to be Rs 45. Based on her estimate, a stock is: